These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3015143)

  • 1. Initial studies on the cellular pharmacology of 2',3-dideoxycytidine, an inhibitor of HTLV-III infectivity.
    Cooney DA; Dalal M; Mitsuya H; McMahon JB; Nadkarni M; Balzarini J; Broder S; Johns DG
    Biochem Pharmacol; 1986 Jul; 35(13):2065-8. PubMed ID: 3015143
    [No Abstract]   [Full Text] [Related]  

  • 2. Potent and selective anti-HTLV-III/LAV activity of 2',3'-dideoxycytidinene, the 2',3'-unsaturated derivative of 2',3'-dideoxycytidine.
    Balzarini J; Pauwels R; Herdewijn P; De Clercq E; Cooney DA; Kang GJ; Dalal M; Johns DG; Broder S
    Biochem Biophys Res Commun; 1986 Oct; 140(2):735-42. PubMed ID: 3022729
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic analysis of 2',3'-dideoxycytidine incorporation into cultured human T lymphoblasts.
    Ullman B; Coons T; Rockwell S; McCartan K
    J Biol Chem; 1988 Sep; 263(25):12391-6. PubMed ID: 2842332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the in vitro infectivity and cytopathic effect of human T-lymphotrophic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV) by 2',3'-dideoxynucleosides.
    Mitsuya H; Broder S
    Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1911-5. PubMed ID: 3006077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological inhibition of in vitro infectivity of human T lymphotropic virus type I.
    Matsushita S; Mitsuya H; Reitz MS; Broder S
    J Clin Invest; 1987 Aug; 80(2):394-400. PubMed ID: 3038956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular metabolism of 2',3'-dideoxycytidine, a compound active against human immunodeficiency virus in vitro.
    Starnes MC; Cheng YC
    J Biol Chem; 1987 Jan; 262(3):988-91. PubMed ID: 2433280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suramin protection of T cells in vitro against infectivity and cytopathic effect of HTLV-III.
    Mitsuya H; Popovic M; Yarchoan R; Matsushita S; Gallo RC; Broder S
    Science; 1984 Oct; 226(4671):172-4. PubMed ID: 6091268
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of T cells against infectivity and cytopathic effect of HTLV-III in vitro.
    Mitsuya H; Matsushita S; Yarchoan R; Broder S
    Princess Takamatsu Symp; 1984; 15():277-88. PubMed ID: 6085846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dideoxycytidine permeation and salvage by mouse leukemia cells and human erythrocytes.
    Plagemann PG; Woffendin C
    Biochem Pharmacol; 1989 Oct; 38(20):3469-75. PubMed ID: 2554924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological inhibition of infectivity of HTLV-III in vitro.
    Mitsuya H; Matsushita S; Harper ME; Broder S
    Cancer Res; 1985 Sep; 45(9 Suppl):4583s-4587s. PubMed ID: 2990689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2',3'-Dideoxycytidine phosphorylation by recombinant mouse and human deoxycytidine kinase.
    Johansson M; Karlsson A
    Adv Exp Med Biol; 1994; 370():711-4. PubMed ID: 7661004
    [No Abstract]   [Full Text] [Related]  

  • 12. Chiral influences of feedback inhibition with dCTP on murine deoxycytidine kinase.
    Tomikawa A; Yamaguchi T; Kawaguchi T; Shudo K; Saneyoshi M
    Nucleic Acids Symp Ser; 1997; (37):181-2. PubMed ID: 9586059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Arabinosyl-5-azacytosine: mechanisms of native and acquired resistance.
    Ahluwalia GS; Cohen MB; Kang GJ; Arnold ST; McMahon JB; Dalal M; Wilson YA; Cooney DA; Balzarini J; Johns DG
    Cancer Res; 1986 Sep; 46(9):4479-85. PubMed ID: 2425954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Initial studies on the cellular pharmacology of 2',3'-dideoxyadenosine, an inhibitor of HTLV-III infectivity.
    Cooney DA; Ahluwalia G; Mitsuya H; Fridland A; Johnson M; Hao Z; Dalal M; Balzarini J; Broder S; Johns DG
    Biochem Pharmacol; 1987 Jun; 36(11):1765-8. PubMed ID: 3107569
    [No Abstract]   [Full Text] [Related]  

  • 15. 2',3'-Dideoxycytidine toxicity in cultured human CEM T lymphoblasts: effects of combination with 3'-azido-3'-deoxythymidine and thymidine.
    Törnevik Y; Eriksson S
    Mol Pharmacol; 1990 Aug; 38(2):237-43. PubMed ID: 2166904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 2',3'-Dideoxynucleoside phosphorylation by deoxycytidine kinase from normal human thymus extracts: activation of potential drugs for AIDS therapy.
    Johnson MA; Johns DG; Fridland A
    Biochem Biophys Res Commun; 1987 Nov; 148(3):1252-8. PubMed ID: 2825680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5'-Nucleotidase activity and arachidonate metabolism in doxorubicin sensitive and resistant P388 cells.
    Ramu A; Glaubiger D; Soprey P; Reaman GH; Feuerstein N
    Br J Cancer; 1984 Apr; 49(4):447-51. PubMed ID: 6324840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Failure of dideoxynucleosides to inhibit human immunodeficiency virus replication in cultured human macrophages.
    Richman DD; Kornbluth RS; Carson DA
    J Exp Med; 1987 Oct; 166(4):1144-9. PubMed ID: 2821152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of nucleoside transport inhibitors on the salvage and toxicity of adenosine and deoxyadenosine in L1210 and P388 mouse leukemia cells.
    Plagemann PG; Wohlhueter RM
    Cancer Res; 1985 Dec; 45(12 Pt 1):6418-24. PubMed ID: 3877568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 2',3'-Dideoxycytidine metabolism in a new drug-resistant cell line.
    Magnani M; Brandi G; Casabianca A; Fraternale A; Schiavano GF; Rossi L; Chiarantini L
    Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):115-23. PubMed ID: 7492300
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.